Recombinantly modified plasmin

Details for Australian Patent Application No. 2008331545 (hide)

Owner Talecris Biotherapeutics, Inc.

Inventors Novokhatny, Valery

Agent Davies Collison Cave

Pub. Number AU-A-2008331545

PCT Pub. Number WO2009/073471

Priority 60/991,148 29.11.07 US

Filing date 25 November 2008

Wipo publication date 11 June 2009

International Classifications

C12N 9/68 (2006.01) Enzymes, e.g. ligases (6.) - Plasmin, i.e. fibrinolysin

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

17 June 2010 PCT application entered the National Phase

  PCT publication WO2009/073471 Priority application(s): WO2009/073471

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008331546-Detection of inducible resistance to macrolide-lincosamide-streptogramin b

2008331538-Systems and methods for the determination of active constraints in a network using slack variables